Summary:
Elligo Clinical Research Center is looking for participants diagnosed with Type 2 Diabetes who are currently using Metformin to participate in a study investigating a once-weekly, self-injectable treatment.
Qualified Participants Must:
• Between 18 and 64 years old
•
Have been diagnosed with Type 2 Diabetes for at least 6 months
•
Currently on a stable dose of Metformin
Qualified Participants May Receive:
- You will be paid $75.00 for each scheduled or unscheduled visit. If a clinic visit is turned into a phone visit, you will be paid $25.00 for each
telephone visit. - Receive access to study-related care and medication at no cost